Mitchell P. Kopin 13D/13G Filings for

Mitchell P. Kopin 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
07:24 am
Sale
2021-12-3113GInVivo Therapeutics Holdings Corporation
NVIVQ
Mitchell P. Kopin34,597
2.500%
-27,631decrease
(-44.40%)
Filing
2021-01-29
06:23 am
Purchase
2020-12-3113GInVivo Therapeutics Holdings Corporation
NVIVQ
Mitchell P. Kopin62,229
6.800%
50,000increase
(+408.88%)
Filing
2020-04-24
4:14 pm
Purchase
2020-04-1513GInVivo Therapeutics Holdings Corporation
NVIVQ
Mitchell P. Kopin12,229
5.900%
12,229increase
(New Position)
Filing